Schizophrenia Research
Volume 90, Issue 1 , Pages 52-61 , February 2007

Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia

  • Ragnar Nesvåg

      Affiliations

    • Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Department of Psychiatric Research, Diakonhjemmet Hospital, P.O. Box 85, Vinderen, 0319 Oslo, Norway. Tel.: +47 22 02 99 52; fax: +47 22 02 99 01.
    • ,
  • Arnoldo Frigessi

      Affiliations

    • Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway
    • ,
  • Erik G. Jönsson

      Affiliations

    • Human Brain Informatics (HUBIN), Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet and Hospital, Stockholm, Sweden
    • ,
  • Ingrid Agartz

      Affiliations

    • Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
    • Human Brain Informatics (HUBIN), Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet and Hospital, Stockholm, Sweden
    • Institute of Psychiatry, University of Oslo, Norway

Received 14 October 2005 ,Revised 9 November 2006 ,Accepted 10 November 2006.

References 

  1. Agartz I, Momenan R, Rawlings RR, Kerich MJ, Hommer DW. Hippocampal volume in patients with alcohol dependence. Arch. Gen. Psychiatry. 1999;56:356–363
  2. Agartz I, Okuguwa G, Nordström M, Greitz D, Magnotta V, Sedvall G. Reliability and reproducibility of brain tissue volumetry from segmented MR scans. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251:255–261
  3. Agartz I, Brag S, Franck J, Hammarberg A, Okugawa G, Svinhufvud K, et al. MR volumetry during acute alcohol withdrawal and abstinence: a descriptive study. Alcohol Alcohol. 2003;38:71–78
  4. Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol. Clin. Exp. Res. 1997;21:613–619
  5. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Third edition, revised. Washington, DC: American Psychiatric Association; 1987;
  6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Fourth edition. Washington, DC: American Psychiatric Association; 1994;
  7. Andreasen NC, Cizadlo T, Harris G, Swayze V, O'Leary DS, Cohen G, et al. Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging. J. Neuropsychiatry Clin. Neurosci. 1993;5:121–130
  8. Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Rüther E. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry. 2004;37(Suppl. 1):S46–S53
  9. Bergman H, Kallmen H. Alcohol use among Swedes and a psychometric evaluation of the Alcohol Use Disorders Identification Test. Alcohol Alcohol. 2002;37:245–251
  10. Bjork JM, Grant SJ, Hommer DW. Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder. Am. J. Psychiatry. 2003;160:2038–2045
  11. Bloomer CW, Langleben DD, Meyerhoff DJ. Magnetic resonance detects brainstem changes in chronic, active heavy drinkers. Psychiatry Res. Neuroimaging. 2004;132:209–218
  12. Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Addiction. 1995;90:1349–1356
  13. Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98(Suppl. 2):S31–S43
  14. Dawe S, Seinen A, Kavanagh D. An examination of the utility of the AUDIT in people with schizophrenia. J. Stud. Alcohol. 2000;61:744–750
  15. Ekholm B, Ekholm A, Adolfsson R, Vares M, Ösby U, Sedvall GC, et al. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord. J. Psychiatry. 2005;59:457–464
  16. Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ. Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol. Clin. Exp. Res. 2002;26:558–564
  17. Harper CG, Kril JJ. Neuropathology of alcoholism. Alcohol Alcohol. 1990;25:207–216
  18. Harris G, Andreasen NC, Cizadlo T, Bailey JM, Bockholt HJ, Magnotta VA, et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J. Comput. Assist. Tomogr. 1999;23:144–154
  19. Harrison PJ. The neuropathological effects of antipsychotic drugs. Schizophr. Res. 1999;40:87–99
  20. Heitmiller DR, Nopoulos PC, Andreasen NC. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. Schizophr. Res. 2004;66:137–142
  21. Hommer D, Momenan R, Rawlings R, Ragan P, Williams W, Rio D, et al. Decreased corpus callosum size among alcoholic women. Arch. Neurol. 1996;53:359–363
  22. Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, et al. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30:924–933
  23. Kane JM, Leucht S, Carpenter D, Docherty JP. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. J. Clin. Psychiatry. 2003;64(Suppl. 12):S5–S19
  24. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet. 1994;344:1434
  25. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am. J. Psychiatry. 2001;158:625–631
  26. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry. 2005;62:361–370
  27. Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC, et al. Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology. 1999;211:781–790
  28. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr. Res. 2004;67:157–166
  29. Mathalon DH, Pfefferbaum A, Lim KO, Rosenbloom MJ, Sullivan EV. Compounded brain volume deficits in schizophrenia–alcoholism comorbidity. Arch. Gen. Psychiatry. 2003;60:245–252
  30. Okugawa G, Sedvall GC, Agartz I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2002;252:120–123
  31. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Mathalon DH, Lim KO. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch. Gen. Psychiatry. 1998;55:905–912
  32. Pfefferbaum A, Rosenbloom MJ, Serventi KL, Sullivan EV. Brain volumes, RBC status, and hepatic function in alcoholics after 1 and 4 weeks of sobriety: predictors of outcome. Am. J. Psychiatry. 2004;161:1190–1196
  33. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: J. Am. Med. Assoc. 1990;264:2511–2518
  34. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RSR, Busa E, et al. Thinning of the cerebral cortex in aging. Cereb. Cortex. 2004;14:721–730
  35. Sapolsky RM. Why stress is bad for your brain. Science. 1996;273:749–750
  36. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88:791–804
  37. Scherk H, Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry. 2006;19:145–150
  38. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res. 2001;49:1–52
  39. Skinner HA, Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J. Stud. Alcohol. 1982;43:1157–1170
  40. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R — Non-patient Version (SCID-NP). New York: Biometrics Research Department, New York State Psychiatric Institute; 1986;
  41. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R — Patient Version (SCID-P). New York: Biometrics Research Department, New York State Psychiatric Institute; 1988;
  42. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry. 2006;188:510–518
  43. Sullivan EV, Mathalon DH, Lim KO, Marsh L, Pfefferbaum A. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol. Psychiatry. 1998;43:118–131
  44. Sullivan EV, Deshmukh A, Desmond JE, Mathalon DH, Rosenbloom MJ, Lim KO, et al. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch. Gen. Psychiatry. 2000;57:894–902
  45. Sullivan EV, Rosenbloom MJ, Serventi KL, Deshmukh A, Pfefferbaum A. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am. J. Psychiatry. 2003;160:1110–1116
  46. Swayze VW, Andersen AE, Andreasen NC, Arndt S, Sato Y, Ziebell S. Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int. J. Eat. Disord. 2003;33:33–44
  47. Talairach J, Tournoux P. Coplanar Stereotaxic Atlas of Human Brain. New York: Thieme Medical; 1988;
  48. Tamagaki C, Sedvall GG, Jönsson EG, Okugawa G, Hall H, Pauli S, et al. Altered white matter/grey matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. Am. J. Psychiatry. 2005;162:2315–2321
  49. Vares M, Ekholm A, Sedvall GC, Hall H, Jönsson EG. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology. 2006;39:286–295
  50. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch. Gen. Psychiatry. 2002;59:553–558
  51. Wolford GL, Rosenberg SD, Drake RE, Mueser KT, Oxman TE, Hoffman D, et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychol. Addict. Behav. 1999;13:313–326

PII: S0920-9964(06)00478-6

doi: 10.1016/j.schres.2006.11.008

Schizophrenia Research
Volume 90, Issue 1 , Pages 52-61 , February 2007

Article Tools